ADAPTABLE Study

A Patient-Centered Pragmatic Clinical Trial

[ADAPTABLE Study @ADAPTABLEstudy]

#ACC21 @ACCinTouch Sharing What We Learned | @PCORI-funded #ADAPTABLEstudy team led by @DCRINews is committed to sharing results with participants. Read our #plainlanguage summary & watch a Town Hall recording featuring patient partners at https://t.co/COKXhQ55IN @PCORnetwork

[ADAPTABLE Study @ADAPTABLEstudy]

In case you missed it, see below for a Q & A with @DCRINews @texhern about the @PCORI-funded #ADAPTABLEstudy @PCORnetwork 👇

[Duke Clinical Research Institute @DCRINews]

The @ADAPTABLEstudy might be completed, but DCRI’s learnings & secondary analyses are not. Read a Q&A w/ DCRI Exec Dir @texhern to learn about how the demonstration project for @PCORnetwork creates a launch pad for future #clinicalresearch with #EHRs: https://t.co/W3OyVkedrc

[ADAPTABLE Study @ADAPTABLEstudy]

What to learn more about #ADAPTABLEstudy? Read below 👇

[Duke Clinical Research Institute @DCRINews]

How did DCRI design the @ADAPTABLEstudy, the landmark pragmatic trial to determine the right dose of aspirin for people with #heartdisease? Read a Q&A with DCRI Executive Director @texhern: https://t.co/W3OyVkedrc @PCORnetwork @PCORI #EHRs

[ADAPTABLE Study @ADAPTABLEstudy]

#ClinicalTrialsDay | Today we honor and thank the patient partners, clinicians, researchers, and the more than 15,000 study participants who volunteered in the #ADAPTABLEstudy to help advance the care of people with #heartdisease. #CTD2021 | https://t.co/COKXhPNukd @PCORI

[ADAPTABLE Study @ADAPTABLEstudy]

On #ClinicalTrialsDay, lessons from @PCORI-funded #ADAPTABLEstudy can help inform the future of #ClinicalResearch from how we engage with patients and clinicians, to leveraging #EHR, and sharing our results with the community. @texhern @schuyler_jones @DCRINews @PCORnetwork 👇

[Duke Clinical Research Institute @DCRINews]

DCRI-led @ADAPTABLEstudy presented results at #ACC21 this past weekend. Read a Q&A with DCRI Executive Director @texhern about what we learned from this landmark study conducted with @PCORnetwork: https://t.co/j4AtwrpXmC

[ADAPTABLE Study @ADAPTABLEstudy]

Via @DCRINews learn more about the @PCORI-funded #ADAPTABLEstudy and how patient partners and clinicians were involved. Visit https://t.co/COKXhQ55IN #pragmatictrials @PCORnetwork

[Duke Clinical Research Institute @DCRINews]

"We chose outcomes that were important to patients and clinicians alike," DCRI's @schuyler_jones says while sharing additional insights on @ADAPTABLEstudy during an #ACC21 deep dive.

[ADAPTABLE Study @ADAPTABLEstudy]

Via @CMichaelGibson | Another example of how patient partners in the @PCORI-funded #ADAPTABLEstudy continue to transform #ClinicalTrials and provide a model for the future. @patientispard @schuyler_jones @DCRINews @PCORnetwork

[C. Michael Gibson MD @CMichaelGibson]

This is the FIRST TIME we have had a participant in a trial present the background for why the study was done and the primary results!

[ADAPTABLE Study @ADAPTABLEstudy]

#ACC21 @ACCinTouch #LBCT | @schuyler_jones of @DCRINews says partnering with patients in the @PCORI-funded #ADAPTABLEstudy provided opportunities to co-create research that keeps participants at the center of the conversation. @PCORnetwork

[ADAPTABLE Study @ADAPTABLEstudy]

Presented at #ACC21 @ACCinTouch & published in @NEJM | @schuyler_jones with @DCRINews @DukeMedSchool shares results from @PCORI-funded #ADAPTABLEstudy, a #randomizedcontrolledtrial through @PCORnetwork. Watch:

[ADAPTABLE Study @ADAPTABLEstudy]

Role of the Research Patient Partner | @patientispard with @ThePaTHNetwork shares what it meant to be an Adaptor in the @PCORI-funded #ADAPTABLEstudy and his vision for the future of #clinicaltrials. @PCORnetwork #patientengagement #ACC21 @ACCinTouch @DCRINews

[ADAPTABLE Study @ADAPTABLEstudy]

#ACC21 @ACCinTouch | Research patient partners, Desiree Davidson @CAPriCORN_CDRN & @patientispard @ThePaTHNetwork discuss the #ADAPTABLEstudy results and how patient partners can transform #clinicaltrials with @schuyler_jones WATCH: https://t.co/KRbGPbjSqK @PCORI @PCORnetwork

[ADAPTABLE Study @ADAPTABLEstudy]

Thank you @SerfasJ. Find out more about @PCORI-funded #ADAPTABLEstudy at https://t.co/COKXhQ55IN

[ADAPTABLE Study @ADAPTABLEstudy]

The #ADAPTABLEstudy, the first #randomizedclinicaltrial of @PCORnetwork provides a model for #patientengagment, leveraging #EHR data, direct-to-participant methods, & participant-reported outcomes. Learn more: https://t.co/COKXhQ55IN @PCORI @DCRINews

[ADAPTABLE Study @ADAPTABLEstudy]

#ACC21 @ACCinTouch | Results from @PCORI-funded #ADAPTABLEstudy indicate lower- and higher-dose aspirin achieve similar protection and safety for people with #heartdisease. Read more about the results at https://t.co/COKXhQ55IN @PCORnetwork @DCRINews @schuyler_jones

[ADAPTABLE Study @ADAPTABLEstudy]

Happening now in today's #ACC21 #LBCT @schuyler_jones will present results from the #ADAPTABLEstudy.

[American College of Cardiology @ACCinTouch]

In a trial designed to try to answer Q of optimal dose of #aspirin for secondary prev. in patients with established atherosclerotic #CVD, no significant diff. found in CV events/major bleeding btwn the 81 mg & 325 mg daily doses. https://t.co/ejnAAh5eLs #ADAPTABLE #ACC21 @NEJM

[ADAPTABLE Study @ADAPTABLEstudy]

Kick off your @ACCinTouch #ACC21 schedule with results from the @PCORI-funded #ADAPTABLEstudy, the first #randomizedcontrolledtrial through @PCORnetwork. 👇

[Duke Clinical Research Institute @DCRINews]

Welcome to the first day of #ACC21! We are excited to hear and present a lot of great science today, including late-breaking results from @adaptablestudy and a couple of interesting panel discussions. Stay tuned! https://t.co/b5wtiSLYX8

[ADAPTABLE Study @ADAPTABLEstudy]

Attending virtual @ACCinTouch #ACC21? Don't miss the #LBCT session today at 9:00 am ET where @schuyler_jones will present results from the @PCORI-funded #ADAPTABLEstudy. @DCRINews @PCORnetwork

[ADAPTABLE Study @ADAPTABLEstudy]

@ilovebenefits @schuyler_jones @ACCinTouch @DCRINews @PCORI @PCORnetwork @texhern @HeartBobH @califf001 @hrhrobertson @a_sharlow @MTRHeart @jinxrumor @patientispard If you are not registered for @ACCinTouch, please visit the #ADAPTABLEstudy website (https://t.co/COKXhQ55IN) tomorrow morning at 9:00 am EST for a #plainlanguage summary of the results, a video recording, and the latest news.

[ADAPTABLE Study @ADAPTABLEstudy]

#ACC21 5/15, 9:00 am ET | Late-Breaking Clinical Trials, Session #402 | One more sleep until @schuyler_jones
presents results from the #ADAPTABLEstudy. Please join us tomorrow @ACCinTouch @DCRINews @PCORI @PCORnetwork

[ADAPTABLE Study @ADAPTABLEstudy]

Happening now @Collaboratory1 #pctGR | Looking forward to listening to this keynote conversation and the workshop series on improving diversity in #pragmatictrials.

[NIH Pragmatic Trials Collaboratory @Collaboratory1]

📣 Starting now on PCT Grand Rounds!

"Diverse Representation Among Clinical Trial Participants: Why It Is Important and How We Can Improve" with Dr. Clyde Yancy of @NUFeinbergMed.

🔗 https://t.co/BJsHs43Ahi #pctGR